CyberKnife S7 Logo

A PROVEN STEREOTACTIC RADIOSURGERY PLATFORM. QUALITY OUTCOMES.

CyberKnife’s precise delivery allows the expansion of stereotactic radiosurgery and stereotactic body radiation therapy treatments to indications not possible to treat on any other radiation therapy machine. 

 

  • Content Types

  • Indications

Partial Breast Irradiation After Lumpectomy

CyberKnife radiosurgery, in conjunction with Synchrony® Respiratory Tracking, precisely delivers the prescription dose over a much shorter course of treatment than conventional radiotherapy.

Ocular Lymphoma

CyberKnife radiosurgery was recommended to provide rapid regression and to maximize the opportunity for local control within the right orbit while minimizing any damage to

Low-Risk Organ-Confined Prostate Cancer

CyberKnife monotherapy produced an early and stable reduction in PSA in a patient with low-risk organ-confined prostate cancer with minimal acute urinary toxicities and no

Pancreatic Adenocarcinoma

The CyberKnife is well-poised to improve the local control rates−this is accomplished with high doses per fraction delivered via a highly conformal approach; improvements in

Spinal Arteriovenous Malformation

The patient was considered to be inoperable, and was referred by the neurosurgeon for radiosurgery using the CyberKnife® Robotic Radiosurgery System.